Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bradford Parsons

Orthopaedic Surgery New York, NY Medical Doctor

NPI 1386601979 CMS profile 244295

5 E 98Th St, Box 1188, New York, NY 10029

Open in the dashboard

General payments

$9,441,784

931 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bradford Parsons of New York, NY is reported in the CMS Open Payments database as having received $9,441,784 across 931 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,599,187 141
2024 General $2,055,949 156
2023 General $1,721,155 146
2022 General $1,186,484 141
2021 General $952,669 150
2020 General $519,981 66
2019 General $406,359 131

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradford Parsons
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Bradford Parsons were reported at $2,599,187. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Bradford Parsons Orthopaedic Surgery median Middle half National median
2019 $406,359 $644 $140–$2,844 $163
2020 $519,981 $312 $75–$1,860 $114
2021 $952,669 $520 $117–$2,495 $132
2022 $1,186,484 $598 $128–$2,731 $149
2023 $1,721,155 $461 $128–$2,264 $160
2024 $2,055,949 $497 $134–$2,475 $164
2025 $2,599,187 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $9,437,570 907 payments
  2. Gotham Surgical Solutions & Devices, Inc. $1,314 3 payments
  3. Sawtooth Surgical Solutions Inc $1,012 3 payments
  4. Exactech, Inc. $498 3 payments
  5. Suvon Surgical LLC $366 3 payments
  6. Stryker Corporation $182 2 payments
  7. Zimmer Biomet Holdings, Inc. $147 1 payment
  8. Paladin Technology Solutions $146 1 payment
  9. Linvatec Corporation $133 1 payment
  10. Smith+Nephew, Inc. $128 2 payments
  11. Other $290 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $8,167,611 28 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $895,360 109 payments
  3. Consulting Fee $287,341 102 payments
  4. Travel and Lodging $76,135 260 payments
  5. Food and Beverage $14,138 431 payments
  6. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System - MGS Glenospheres $6,965,179 12 payments
  2. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System $3,247,447 12 payments
  3. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System $3,247,447 12 payments
  4. Arthrex Upper Extremity - Implants - Instability - FiberTak - Tensionable Knotless $2,321,726 4 payments
  5. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System - MGS Baseplates $2,321,726 4 payments
  6. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System $1,926,710 4 payments
  7. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System $1,926,710 4 payments
  8. Arthrex Upper Extremity - Implants - Instability - FiberTak $1,926,710 4 payments
  9. Arthrex Arthroplasty & Shoulder Fracture - Implants - Revers Total Shoulder - Modular Glenoid System $1,926,710 4 payments
  10. ARTHREX Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System $1,660,508 8 payments
  11. Other $12,912,341 106 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$189,086

Of which drugs: $4,329

Medicare patients

458

Average age 75

Services billed

1,741

298 women, 160 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 64%
Ischemic heart disease 34%
Diabetes 32%
Osteoporosis 24%
Depression 23%
Cancer 17%
Chronic kidney disease 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 101 466 $353

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

931 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record